{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:22:20Z","timestamp":1783394540614,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["POWR.05.02.00-00-0149\/15"],"award-info":[{"award-number":["POWR.05.02.00-00-0149\/15"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["POPC.02.02.00-00-0015\/18-00"],"award-info":[{"award-number":["POPC.02.02.00-00-0015\/18-00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>To estimate the actual incidence and prevalence of psoriatic arthritis (PsA) within a 9-year timeframe in Poland. Patients were defined as having PsA if they had at least two visits more than 90 days apart with ICD-10 codes M07.0, M07.1, M07.2, M07.3, or L40.5 and filled at least one reimbursed prescription for peripheral or axial PsA-specific treatments during this period (including methotrexate, sulfasalazine, ciclosporin, leflunomide, biologics, targeted synthetic drugs, or non-steroidal anti-inflammatory drugs). Data was obtained from the nationwide public payer database, considering gender, age, and region of residence. We observed an incidence rate of 1.1 per 100,000 inhabitants in 2021, compared to 13.2 in 2013. Regarding the age of the first diagnosis, the peak incidence rate decreased, with a more pronounced decline in men. The prevalence of PsA rose from 72.5 individuals per 100,000 in 2013 to 95.5 in 2021, representing approximately 0.1% of the total population in Poland, with a significant predominance of women among patients over 55 years of age. The decline in PsA incidence may be influenced by a strict case definition and improved access to treatment. Higher prevalence in older women suggests potential gender-related differences. The lower peak incidence and younger diagnosis age in men raise questions about whether lower PsA prevalence in older males is linked to higher mortality due to longer disease duration and comorbidities. Further research is needed to clarify these findings.<\/jats:p>","DOI":"10.1007\/s00296-025-05966-5","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:21:29Z","timestamp":1756812089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psoriatic arthritis incidence and prevalence trajectory in Poland\u2014public-payer, national-level, long-term data"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7857-347X","authenticated-orcid":false,"given":"Magdalena","family":"Krajewska-W\u0142odarczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-6620","authenticated-orcid":false,"given":"Mateusz","family":"Szel\u0105g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3999-8093","authenticated-orcid":false,"given":"Bogdan","family":"Batko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-7194","authenticated-orcid":false,"given":"Marcin","family":"Stajszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5065-2582","authenticated-orcid":false,"given":"Micha\u0142","family":"Orlea\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2902-8029","authenticated-orcid":false,"given":"Krzysztof","family":"Podw\u00f3jcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3890-9370","authenticated-orcid":false,"given":"Jakub","family":"Sowi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6121-4190","authenticated-orcid":false,"given":"Maria","family":"\u015awiderek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-4367","authenticated-orcid":false,"given":"Marek","family":"Brzosko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4340-6991","authenticated-orcid":false,"given":"Agata","family":"\u015amiglewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-1830","authenticated-orcid":false,"given":"Brygida","family":"Kwiatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9581-0601","authenticated-orcid":false,"given":"Zbigniew","family":"\u017buber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"5966_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"LC Coates","year":"2017","unstructured":"Coates LC, Helliwell PS (2017) Psoriatic Arthritis: state of the Art review. Clin Med (Lond) 17:65\u201370. https:\/\/doi.org\/10.7861\/clinmedicine.17-1-65","journal-title":"Clin Med (Lond)"},{"key":"5966_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00296-010-1699-4","volume":"32","author":"N Cak\u0131r","year":"2012","unstructured":"Cak\u0131r N, Pamuk \u00d6N, Dervi\u015f E, Imery\u00fcz N, Uslu H, Benian \u00d6, Elel\u00e7i E, Erdem G, Sarvan FO, Senocak M (2012) The prevalences of some rheumatic diseases in Western Turkey: Havsa study. Rheumatol Int 32:895\u2013908. https:\/\/doi.org\/10.1007\/s00296-010-1699-4","journal-title":"Rheumatol Int"},{"key":"5966_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/03009740903544212","volume":"39","author":"P Hanova","year":"2010","unstructured":"Hanova P, Pavelka K, Holcatova I, Pikhart H (2010) Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol 39:310\u2013317. https:\/\/doi.org\/10.3109\/03009740903544212","journal-title":"Scand J Rheumatol"},{"key":"5966_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"4","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am 4:545\u2013568. https:\/\/doi.org\/10.1016\/j.rdc.2015.07.001","journal-title":"Rheum Dis Clin North Am"},{"key":"5966_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/acr.22831","volume":"68","author":"C Stolwijk","year":"2016","unstructured":"Stolwijk C, van Onna M, Boonen A, van Tubergen A (2016) Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res (Hoboken) 68:1320\u20131331. https:\/\/doi.org\/10.1002\/acr.22831","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5966_CR6","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/rheumatology\/keae198","volume":"63","author":"S Lembke","year":"2024","unstructured":"Lembke S, Macfarlane GJ, Jones GT (2024) The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis. Rheumatology (Oxford) 63:3211\u20133220. https:\/\/doi.org\/10.1093\/rheumatology\/keae198","journal-title":"Rheumatology (Oxford)"},{"key":"5966_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2991\/jegh.k.190920.001","volume":"9","author":"DST J\u00fanior","year":"2019","unstructured":"J\u00fanior DST, de Oliveira CM, de Assis EM (2019) Population-based study of 24 autoimmune diseases carried out in a Brazilian microregion. J Epidemiol Glob Health 9:243\u2013251. https:\/\/doi.org\/10.2991\/jegh.k.190920.001","journal-title":"J Epidemiol Glob Health"},{"key":"5966_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/03009742.2021.1997436","volume":"52","author":"AM Kerola","year":"2023","unstructured":"Kerola AM, Rollefstad S, Kazemi A, Wibetoe G, Sexton J, Mars N, Kauppi M, Kvien TK, Haavardsholm EA, Semb AG (2023) Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scand J Rheumatol 52:42\u201350. https:\/\/doi.org\/10.1080\/03009742.2021.1997436","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"5966_CR9","doi-asserted-by":"publisher","DOI":"10.23889\/ijpds.v9i1.2407","volume":"9","author":"SD Emerson","year":"2024","unstructured":"Emerson SD, McLinden T, Sereda P, Yonkman AM, Trigg J, Peterson S, Hogg RS, Salters KA, Lima VD, Barrios R (2024) Secondary use of routinely collected administrative health data for epidemiologic research: answering research questions using data collected for a different purpose. Int J Popul Data Sci 9(1):2407. https:\/\/doi.org\/10.23889\/ijpds.v9i1.2407","journal-title":"Int J Popul Data Sci"},{"key":"5966_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ssresearch.2016.04.015","volume":"59","author":"R Connelly","year":"2016","unstructured":"Connelly R, Playford CJ, Gayle V, Dibben C (2016) The role of administrative data in the big data revolution in social science research. Soc Sci Res 59:1\u201312. https:\/\/doi.org\/10.1016\/j.ssresearch.2016.04.015","journal-title":"Soc Sci Res"},{"key":"5966_CR11","doi-asserted-by":"publisher","DOI":"10.23889\/ijpds.v3i4.918","author":"K McGrail","year":"2018","unstructured":"McGrail K, Jones K (2018) Population Data Science: The science of data about people. Int J Popul Data Sci 3(4). https:\/\/doi.org\/10.23889\/ijpds.v3i4.918.","journal-title":"Int J Popul Data Sci"},{"key":"5966_CR12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/rheumatology\/keaa448","volume":"60","author":"L Pina Vegas","year":"2021","unstructured":"Pina Vegas L, Sbidian E, Penso L, Claudepierre P (2021) Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database. Rheumatology (Oxford) 60:1243\u20131251. https:\/\/doi.org\/10.1093\/rheumatology\/keaa448","journal-title":"Rheumatology (Oxford)"},{"key":"5966_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100519","volume":"23","author":"IC Scott","year":"2022","unstructured":"Scott IC, Whittle R, Bailey J, Twohig H, Hider SL, Mallen CD, Muller S, Jordan KP (2022) Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data. Lancet Reg Health 23:100519. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100519","journal-title":"Lancet Reg Health"},{"key":"5966_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3899\/jrheum.180670","volume":"46","author":"HG Tekin","year":"2019","unstructured":"Tekin HG, Wu JJ, Burge R, Birt J, Egeberg A (2019) Burden and disease characteristics of patients with psoriatic arthritis: A Population-based Cross-sectional study. J Rheumatol 46:716\u2013720. https:\/\/doi.org\/10.3899\/jrheum.180670","journal-title":"J Rheumatol"},{"key":"5966_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12325-020-01522-8","volume":"38","author":"C Grellmann","year":"2021","unstructured":"Grellmann C, Dombrowsky W, Fabricius V, Suruki R, Sheahan A, Joeres L (2021) Epidemiology and treatment of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis in Germany: a real-world evidence study. Adv Ther 38:366\u2013385. https:\/\/doi.org\/10.1007\/s12325-020-01522-8","journal-title":"Adv Ther"},{"key":"5966_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00296-020-04734-x","volume":"41","author":"M T\u0142ustochowicz","year":"2021","unstructured":"T\u0142ustochowicz M, Wierzba W, Marczak M, T\u0142ustochowicz W, \u015aliwczy\u0144ski A, Raciborski F, Kwiatkowska B, Brzozowska M, Jacyna A, Kisiel B (2021) Trends in psoriatic arthritis epidemiology in Poland. Rheumatol Int 41:139\u2013145. https:\/\/doi.org\/10.1007\/s00296-020-04734-x","journal-title":"Rheumatol Int"},{"key":"5966_CR17","unstructured":"Polish Ministry of Digital Affairs register. https:\/\/www.gov.pl\/web\/cyfryzacja\/rejestr-stanu-cywilnego. Accessed 20 Nov 2024"},{"key":"5966_CR18","unstructured":"Polish Central Statistical Office registe. https:\/\/stat.gov.pl\/obszary-tematyczne\/ludnosc\/ludnosc. Accessed 20 Nov 2024"},{"key":"5966_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald O, Ogdie A, Chandran V, Coates LC, Kavanaugh A, Tillett W, Leung YY, deWit M, Scher JU, Mease PJ (2021) Psoriatic arthritis. Nat Rev Dis Primers 7:59. https:\/\/doi.org\/10.1038\/s41572-021-00293-y","journal-title":"Nat Rev Dis Primers"},{"key":"5966_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2478\/ahem-2021-0033","volume":"75","author":"A Owczarczyk-Saczonek","year":"2021","unstructured":"Owczarczyk-Saczonek A, Kasprowicz-Furma\u0144czyk M, Krajewska-W\u0142odarczyk M, Griffiths C (2021) Does the lifestyle of patients with psoriasis affect their illness? Advances in hygiene and experimental medicine. 75:643\u2013654. https:\/\/doi.org\/10.2478\/ahem-2021-0033","journal-title":"Advances in hygiene and experimental medicine."},{"key":"5966_CR21","unstructured":"World obesity prevalence data \u2013 Poland. https:\/\/data.worldobesity.org\/country\/poland-173\/#data_prevalence. Accessed 20 Nov 2024"},{"key":"5966_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/rheumatology\/keae399","volume":"64","author":"C L\u00f3pez-Medina","year":"2025","unstructured":"L\u00f3pez-Medina C, McGonagle D, Gossec L (2025) Subclinical psoriatic arthritis and disease interception-where are we in 2024? Rheumatology (Oxford). 64:56\u201364. https:\/\/doi.org\/10.1093\/rheumatology\/keae399","journal-title":"Rheumatology (Oxford)."},{"key":"5966_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40257-023-00801-8","volume":"24","author":"A Aronovich","year":"2023","unstructured":"Aronovich A, Novikov I, Pavlovsky L (2023) Do biologic treatments for psoriasis lower the risk of psoriatic arthritis? A systematic review. Am J Clin Dermatol 24:865\u2013873. https:\/\/doi.org\/10.1007\/s40257-023-00801-8","journal-title":"Am J Clin Dermatol"},{"key":"5966_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/annrheumdis-2013-203862","volume":"74","author":"M Hoff","year":"2015","unstructured":"Hoff M, Gulati AM, Romundstad PR, Kavanaugh A, Haugeberg G (2015) Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Tr\u00f8ndelag health study (HUNT). Ann Rheum Dis 74:60\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203862","journal-title":"Ann Rheum Dis"},{"key":"5966_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/03009740802609558","volume":"38","author":"JC Nossent","year":"2009","unstructured":"Nossent JC, Gran JT (2009) Epidemiological and clinical characteristics of psoriatic arthritis in Northern Norway. Scand J Rheumatol 38:251\u2013255. https:\/\/doi.org\/10.1080\/03009740802609558","journal-title":"Scand J Rheumatol"},{"key":"5966_CR26","first-page":"2460","volume":"30","author":"E Savolainen","year":"2003","unstructured":"Savolainen E, Kaipiainen-Sepp\u00e4nen O, Kr\u00f6ger L, Luosuj\u00e4rvi R (2003) Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 30:2460\u20132468 PMID: 14677193","journal-title":"J Rheumatol"},{"key":"5966_CR27","first-page":"2641","volume":"30","author":"Y Alamanos","year":"2003","unstructured":"Alamanos Y, Papadopoulos NG, Voulgari PV, Siozos C, Psychos DN, Tympanidou M, Drosos AA (2003) Epidemiology of psoriatic arthritis in Northwest Greece, 1982\u20132001. J Rheumatol 30:2641\u20132644","journal-title":"J Rheumatol"},{"key":"5966_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10067-014-2746-4","volume":"34","author":"S D\u00f6nmez","year":"2015","unstructured":"D\u00f6nmez S, Pamuk \u00d6N, Akker M, Ak R (2015) Clinical features and types of articular involvement in patients with psoriatic arthritis. Clin Rheumatol 34:1091\u20131096. https:\/\/doi.org\/10.1007\/s10067-014-2746-4","journal-title":"Clin Rheumatol"},{"key":"5966_CR29","first-page":"554","volume":"28","author":"S Hukuda","year":"2001","unstructured":"Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y, Makino H, Shibata T, Shingu M, Sakou T, Shichikawa K (2001) Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan ankylosing spondylitis society. J Rheumatol 28:554\u2013549 PMID: 11296958","journal-title":"J Rheumatol"},{"key":"5966_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3899\/jrheum.080691","volume":"36","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM (2009) Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol 36:361\u2013367. https:\/\/doi.org\/10.3899\/jrheum.080691","journal-title":"J Rheumatol"},{"key":"5966_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/rheumatology\/keq369","volume":"50","author":"ER Soriano","year":"2011","unstructured":"Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J, Catoggio LJ (2011) Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organisation-based study. Rheumatology (Oxford) 50:729\u2013734. https:\/\/doi.org\/10.1093\/rheumatology\/keq369","journal-title":"Rheumatology (Oxford)"},{"key":"5966_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13075-017-1497-4","volume":"20","author":"L Eder","year":"2018","unstructured":"Eder L, Cohen AD, Feldhamer I, Greenberg-Dotan S, Batat E, Zisman D (2018) The epidemiology of psoriatic arthritis in Israel - a population-based study. Arthritis Res Ther 20:3. https:\/\/doi.org\/10.1186\/s13075-017-1497-4","journal-title":"Arthritis Res Ther"},{"key":"5966_CR33","first-page":"177","volume":"22","author":"AM Al-Awadhi","year":"2004","unstructured":"Al-Awadhi AM, Olusi SO, Al-Saeid K, Moussa M, Shehab D, Al-Zaid N, Al-Herz A, Al-Jarallah K (2004) Musculoskeletal pain, disability and health-seeking behavior in adult Kuwaitis using a validated Arabic version of the WHO-ILAR COPCORD core questionnaire. Clin Exp Rheumatol 22:177\u2013183 PMID: 15083885","journal-title":"Clin Exp Rheumatol"},{"key":"5966_CR34","doi-asserted-by":"publisher","first-page":"e0234556","DOI":"10.1371\/journal.pone.0234556","volume":"15","author":"A Romero P\u00e9rez","year":"2020","unstructured":"Romero P\u00e9rez A, Queiro R, Seoane-Mato D, Graell E, Chamizo E, Chaves Chaparro L, Rojas Herrera S, Pons Dolset J, Polo Ost\u00e1riz MA, Ruiz-Alejos Garrido S, Mac\u00eda-Villa C, Cruz-Valenciano A, Gonz\u00e1lez G\u00f3mez ML, S\u00e1nchez-Piedra C, D\u00edaz-Gonz\u00e1lez F, Bustabad-Reyes S, Proyecto EPISER2016 WorkingGroup (2020) Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study. PLoS One 15:e0234556. https:\/\/doi.org\/10.1371\/journal.pone.0234556.","journal-title":"PLoS One"},{"key":"5966_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00296-024-05760-9","volume":"45","author":"S Chandrashekara","year":"2025","unstructured":"Chandrashekara S, Shenoy P, Kumar U, Pandya S, Ghosh A, Khare A, Dudam R, Goswami RP (2025) Increase in comorbidities with age among patients with psoriatic arthritis: a multicenter observational study. Rheumatol Int 45:23. https:\/\/doi.org\/10.1007\/s00296-024-05760-9","journal-title":"Rheumatol Int"},{"key":"5966_CR36","doi-asserted-by":"publisher","first-page":"adv4591","DOI":"10.2340\/actadv.v103.4591","volume":"103","author":"SM Solberg","year":"2023","unstructured":"Solberg SM (2023) Psoriasis in Norway: a prescription-based registry study of incidence and prevalence. Acta Derm Venereol 103:adv4591. https:\/\/doi.org\/10.2340\/actadv.v103.4591","journal-title":"Acta Derm Venereol"},{"key":"5966_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/ddg.15269","volume":"22","author":"K Hagenstr\u00f6m","year":"2024","unstructured":"Hagenstr\u00f6m K, M\u00fcller K, Garbe C, Augustin M (2024) Prevalence of psoriasis and psoriatic arthritis in Germany - analysis of claims data. JDDG J Dtsch Dermatol Ges 22:45\u201354. https:\/\/doi.org\/10.1111\/ddg.15269","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"5966_CR38","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM (2021) Psoriasis prevalence in adults in the united States. JAMA Dermatol 157:940\u2013946. https:\/\/doi.org\/10.1001\/jamadermatol.2021.2007","journal-title":"JAMA Dermatol"},{"key":"5966_CR39","doi-asserted-by":"publisher","first-page":"e006450","DOI":"10.1136\/bmjopen-2014-006450","volume":"5","author":"K Kubota","year":"2015","unstructured":"Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H, Nakagawa H (2015) Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese National claims database. BMJ Open 5:e006450. https:\/\/doi.org\/10.1136\/bmjopen-2014-006450","journal-title":"BMJ Open"},{"key":"5966_CR40","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16655","volume":"134","author":"M Stajszczyk","year":"2024","unstructured":"Stajszczyk M, Kwiatkowska B, \u017buber ZM, Batko B (2024) Access to biologics and JAK inhibitors for the treatment of rheumatic diseases in the biosimilars era in Poland: nation-level study. Pol Arch Intern Med 134:16655. https:\/\/doi.org\/10.20452\/pamw.16655","journal-title":"Pol Arch Intern Med"},{"key":"5966_CR41","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1186\/s12889-024-20147-y","volume":"24","author":"ZDV Abel","year":"2024","unstructured":"Abel ZDV, Roope LSJ, Duch R, Clarke PM (2024) Access to healthcare services during the COVID-19 pandemic: a cross-sectional analysis of income and user-access across 16 economically diverse countries. BMC Public Health 24:2678. https:\/\/doi.org\/10.1186\/s12889-024-20147-y","journal-title":"BMC Public Health"},{"key":"5966_CR42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00296-024-05591-8","volume":"44","author":"M Krajewska-W\u0142odarczyk","year":"2024","unstructured":"Krajewska-W\u0142odarczyk M, Szel\u0105g M, Batko B, \u017buber Z, Orlea\u0144ski M, Podw\u00f3jcic K, Sowi\u0144ski J, Jopek J, \u015awiderek M, Maluchnik M, Brzosko M, \u015amiglewska A, Kwiatkowska B (2024) Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatol Int 44:1155\u20131163. https:\/\/doi.org\/10.1007\/s00296-024-05591-8","journal-title":"Rheumatol Int"},{"key":"5966_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12969-025-01065-8","volume":"23","author":"Z \u017buber","year":"2025","unstructured":"\u017buber Z, Podw\u00f3jcic K, Szel\u0105g M, Krajewska-W\u0142odarczyk M, Batko K, Orlea\u0144ski M, Sowi\u0144ski J, \u015awiderek M, \u015amiglewska A, Maluchnik M, Brzosko M, Kwiatkowska B, Stajszczyk M, Batko B (2025) Epidemiology and comorbidity of juvenile idiopathic arthritis in Poland \u2013 a nationwide study. Pediatr Rheumatol 23:33. https:\/\/doi.org\/10.1186\/s12969-025-01065-8","journal-title":"Pediatr Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05966-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:15:18Z","timestamp":1760523318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05966-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["5966"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05966-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This analysis relies solely on data obtained from the National Health Fund (NFZ) electronic databases. Obtaining institutional ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"212"}}